NCT02777619View on ClinicalTrials.gov

Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Pharmacodynamic Interaction
Interventions
DRUG

0.0ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.0ng/ml

DRUG

0.4ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.4ng/ml

DRUG

0.6ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.6ng/ml

DRUG

0.8ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.8ng/ml

DRUG

Propofol

Trial Locations (1)

510010

Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou

All Listed Sponsors
lead

Guangzhou General Hospital of Guangzhou Military Command

OTHER

NCT02777619 - Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia | Biotech Hunter | Biotech Hunter